Issued Patents All Time
Showing 1–25 of 96 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391958 | Compositions and methods for treating cancer with anti-CD38 immunotherapy | Dina Schneider, Rimas J. Orentas, Boro Dropulic, Zhongyu Zhu | 2025-08-19 |
| 12378321 | ADAM17 binding molecules and uses thereof | Dimitar B. Nikolov, Nayanendu Saha, Zhongyu Zhu, Dorothea Robev, Thomas Edgeworth White | 2025-08-05 |
| 12037403 | Compositions and methods for treating cancer with anti-CD123 immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2024-07-16 |
| 12037404 | Human monoclonal antibodies against EphA4 and their use | Nancy Yuk-Yu Ip, Kit Yu Fu, Wing Yu Fu, Tianlei Ying | 2024-07-16 |
| 12018077 | Methods of treatments using antigen-binding proteins targeting CD56 | Michel Sadelain, Reuben Benjamin, Yang Feng | 2024-06-25 |
| 12012455 | Human monoclonal antibodies specific for FLT3 and uses thereof | Weizao Chen, Terry J. Fry, Christopher D. Chien | 2024-06-18 |
| 11970528 | Compositions and methods for treating cancer with anti-mesothelin immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2024-04-30 |
| 11939377 | Affinity matured CD22-specific monoclonal antibody and uses thereof | Zhongyu Zhu, Sneha Ramakrishna, Terry J. Fry | 2024-03-26 |
| 11878052 | Compositions and methods for treating cancer with anti-CD22 immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2024-01-23 |
| 11851498 | Anti-CD276 antibodies (B7H3) | Zhongyu Zhu, Bradley St. Croix, Steven Seaman, Saurabh Saha, Xiaoyan Zhang +2 more | 2023-12-26 |
| 11814440 | Glypican 2 as a cancer marker and therapeutic target | John Maris, Kristopher R. BOSSE, Zhongyu Zhu, Dontcho V. Jelev | 2023-11-14 |
| 11807682 | M971 chimeric antigen receptors | Rimas J. Orentas, Ira H. Pastan, Crystal L. Mackall | 2023-11-07 |
| 11708408 | Compositions and methods for treating cancer with anti-CD19 immunotherapy | Dina Schneider, Rimas J. Orentas, Boro Dropulic, Zhongyu Zhu | 2023-07-25 |
| 11702472 | Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors | Prasad S. Adusumilli, Michel Sadelain, Yang Feng | 2023-07-18 |
| 11680093 | Monoclonal antibodies that specifically bind to matrilin 3 and their use | Jeffrey Baron, Crystal Sao Fong Cheung, Julian Chun Kin Lui, Zhongyu Zhu | 2023-06-20 |
| 11512138 | Anti-CD276 polypeptides, proteins, and chimeric antigen receptors | Rimas J. Orentas, Zhongyu Zhu, Crystal L. Mackall, Bradley St. Croix, Saurabh Saha | 2022-11-29 |
| 11464801 | Compositions and methods for treating cancer with anti-CD33 immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2022-10-11 |
| 11453719 | Compositions and methods for treating cancer with anti-ROR1 immunotherapy | Rimas J. Orentas, Dina Schneider, Boro Dropulic, Zhongyu Zhu | 2022-09-27 |
| 11389480 | Human monoclonal antibody targeting TNFR2 for cancer immunotherapy | Joost Oppenheim, De Yang, Xin Chen, Zhongyu Zhu | 2022-07-19 |
| 11236171 | Human monoclonal antibodies specific for FLT3 and uses thereof | Weizao Chen, Terry J. Fry, Christopher D. Chien, Haiying Qin | 2022-02-01 |
| 11103533 | Compositions and methods for treating cancer with anti-CD38 immunotherapy | Dina Schneider, Rimas J. Orentas, Boro Dropulic, Zhongyu Zhu | 2021-08-31 |
| 11078286 | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use | Javed Khan, Sivasubramanian Baskar, Rimas J. Orentas, Zhongyu Zhu, Tai Chi Cheuk | 2021-08-03 |
| 11066479 | Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof | Mitchell Ho, Nan Li | 2021-07-20 |
| 11034757 | Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2021-06-15 |
| 11033621 | Combination therapies targeting tumor-associated stroma or tumor cells | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2021-06-15 |